What policy makers need to know about COVID-19 protective immunity
File(s)
Author(s)
Altmann, Daniel M
Douek, Daniel C
Boyton, Rosemary J
Type
Journal Article
Date Issued
2020-05-16
Date Acceptance
2020-04-23
Citation
The Lancet, 2020, 395 (10236), pp.1527-1529
ISSN
0140-6736
Publisher
Elsevier
Start Page
1527
End Page
1529
Journal / Book Title
The Lancet
Volume
395
Issue
10236
Copyright Statement
© 2020 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32353328
PII: S0140-6736(20)30985-5
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
SARS CORONAVIRUS
VACCINATION
RESPONSES
Administrative Personnel
Antibodies, Viral
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Coronavirus Infections
Humans
Immunity, Herd
Mass Vaccination
Pandemics
Pneumonia, Viral
SARS-CoV-2
Humans
Pneumonia, Viral
Coronavirus Infections
Antibodies, Viral
Clinical Laboratory Techniques
Immunity, Herd
Administrative Personnel
Mass Vaccination
Pandemics
Betacoronavirus
COVID-19
SARS-CoV-2
COVID-19 Testing
11 Medical and Health Sciences
General & Internal Medicine
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2020-04-27